What Is VELscope Oral Cancer Screening?
VELscope is a handheld, light-based device that helps dentists and oral pathologists spot abnormal tissue in your mouth. It works by shining a specific wavelength of blue-violet light onto your oral tissues and observing how those tissues fluoresce (glow back). The device is classified as an adjunctive aid, meaning it supplements a standard visual and tactile oral exam rather than replacing it. [1]
The name VELscope stands for Visually Enhanced Lesion scope. The technology relies on a natural phenomenon called tissue autofluorescence. Healthy cells contain molecules called fluorophores that absorb blue light and re-emit a pale green glow. When cells are damaged, inflamed, or undergoing precancerous or cancerous changes, those fluorophores break down and the tissue appears dark under the VELscope light. [7]
Oral cancer affects roughly 54,000 people in the United States each year, according to estimates from the American Dental Association. [11] Early detection dramatically improves outcomes, yet many oral cancers are not caught until advanced stages. Adjunctive screening tools like VELscope aim to help clinicians identify suspicious tissue earlier, when treatment is typically less invasive and survival rates are higher. [8]
How VELscope Blue-Light Detection Works
VELscope uses a narrow band of blue-violet light, between 400 and 460 nanometers, to excite natural fluorescent molecules in your oral tissue. Here is a step-by-step look at the science and what happens during the exam.
The Science of Tissue Autofluorescence
Your mouth's soft tissues contain natural fluorophores, molecules such as collagen cross-links, FAD (flavin adenine dinucleotide), and NADH (nicotinamide adenine dinucleotide). When blue-violet light hits healthy tissue, these fluorophores absorb the energy and re-emit it as a visible pale green glow. This process is called autofluorescence because no external dyes are needed. [4]
When cells become dysplastic (showing early abnormal changes) or malignant (cancerous), several things happen at the tissue level. The collagen matrix in the connective tissue breaks down. Blood vessel density increases. The fluorophore concentration drops. As a result, the abnormal tissue absorbs the blue light but does not glow green. Instead, it appears as a dark patch against the surrounding healthy green fluorescence. [7] A systematic review of light-based diagnostic tools confirmed that autofluorescence visualization can reveal structural and biochemical changes beneath the tissue surface that are invisible to the naked eye. [4]
What Happens During a VELscope Exam
The room lights are dimmed. Your clinician holds the VELscope handpiece a few inches from your mouth. You do not need to swallow any dye or rinse with a special solution. The blue light is safe and does not cause heat or discomfort.
The clinician looks through a filtered viewing window on the device. This window blocks reflected blue light and allows only the green fluorescence to pass through. Healthy tissue glows a bright apple green. Areas of concern appear as dark, non-fluorescent patches. The entire mouth can be scanned in about two minutes. [5]
If a dark area is found, your clinician will compare it to a conventional visual exam under white light. Not every dark patch is cancer. Inflammation, recent trauma, amalgam tattoos (discoloration from dental filling material), and even some benign infections can cause fluorescence loss. If the area remains suspicious, a biopsy (a small tissue sample sent to a lab) is the next step. [6]
What Conditions Is VELscope Used For?
VELscope is primarily used to help detect oral cancers and potentially malignant disorders (OPMDs), but clinicians also use it for several related purposes.
Oral Cancer and Precancer Screening
The main clinical application of VELscope is screening for oral squamous cell carcinoma (OSCC), the most common type of oral cancer, and its precursors. Precancerous conditions include leukoplakia (white patches), erythroplakia (red patches), and oral submucous fibrosis. A large prospective study of 563 patients found that autofluorescence imaging helped clinicians determine which oral potentially malignant disorders required biopsy. The technique identified lesions with altered fluorescence that were later confirmed as dysplastic or malignant. [6]
An oral pathologist may use VELscope alongside a standard clinical exam to decide exactly where to biopsy within a large suspicious area. Choosing the most representative spot can improve diagnostic accuracy. [7]
Monitoring Tobacco and Alcohol Users
Patients who use tobacco or consume alcohol heavily face a significantly higher risk of developing oral mucosal lesions. A retrospective study of 2,400 patients found that VELscope-assisted examination identified a higher prevalence of oral lesions among tobacco and alcohol users compared with non-users. [3] This makes VELscope a practical monitoring tool during routine visits for higher-risk patients.
The device does not diagnose cancer on its own. It highlights areas that warrant closer inspection. For patients with known risk factors, periodic VELscope screening may help catch changes earlier than a visual exam alone. [8]
Evidence and FDA Clearance Status
VELscope received FDA 510(k) clearance as an adjunctive mucosal examination device. FDA clearance means the device was found to be substantially equivalent to a legally marketed device. This is different from FDA approval, which requires more rigorous clinical trials proving safety and efficacy. VELscope is cleared for use as a supplement to, not a replacement for, the standard visual and tactile oral exam.
What Published Studies Show
A systematic review by Cicciù et al. evaluated the VELscope fluorescence method across multiple studies and concluded that the device shows promise as a chair-side screening adjunct. The review noted that VELscope typically demonstrates high sensitivity (ability to detect true positives) but lower specificity (ability to rule out false positives). This means the device is generally good at catching abnormal tissue but may also flag tissue that turns out to be benign. [7]
A large prospective study by Shi et al. examined 563 patients with oral potentially malignant disorders using autofluorescence imaging. The study found that fluorescence visualization helped guide biopsy site selection, particularly in cases where lesions had mixed clinical appearances. Autofluorescence helped identify high-risk areas within larger lesions. [6]
A broader narrative review of adjunctive aids for detecting oral squamous cell carcinoma noted that while autofluorescence devices like VELscope add value beyond visual inspection alone, no single adjunctive tool has yet replaced biopsy and histopathological examination as the definitive diagnostic method. [1] A separate systematic review of light-based diagnostic technologies confirmed that autofluorescence remains one of the most studied non-invasive approaches in oral cancer detection. [4]
Professional Society Positions
The American Dental Association recognizes the importance of routine oral cancer screening as part of dental exams. [11] The American Academy of Oral and Maxillofacial Pathology emphasizes that early detection and proper diagnosis of oral mucosal lesions are critical for patient outcomes. [10] Neither organization has issued a specific mandate requiring VELscope use, but both support the principle that adjunctive tools may assist trained clinicians in identifying suspicious tissue.
The clinical consensus remains that VELscope is most valuable when used by an experienced clinician who can interpret fluorescence patterns in context. The device does not replace clinical judgment, and a biopsy is always required to confirm a diagnosis of cancer or dysplasia. [5]
Benefits and Limitations of VELscope
VELscope offers several advantages as a screening tool, but it also has real limitations that patients should understand.
Advantages
The exam is completely non-invasive. No tissue is removed, no dyes are swallowed, and no pain is involved. The entire screening typically takes two to three minutes and can be performed during a routine dental visit. [5]
VELscope can reveal tissue changes beneath the surface that are not visible to the naked eye under standard white light. A systematic review confirmed that autofluorescence visualization detects structural and metabolic changes in tissue before they become clinically obvious. [4] This may help catch precancerous changes at an earlier, more treatable stage.
The device also helps clinicians choose better biopsy sites. In lesions that are large or have mixed appearances, VELscope can highlight the area most likely to be dysplastic, improving the diagnostic yield of the biopsy. [6]
- Non-invasive, painless, and fast (about two to three minutes)
- No dyes, rinses, or preparation required
- Can detect subsurface tissue changes invisible under white light [4]
- Helps guide biopsy site selection for more accurate diagnosis [6]
- Useful for monitoring patients with elevated risk factors such as tobacco or alcohol use [3]
Limitations
VELscope has a well-documented limitation around specificity. Many benign conditions cause fluorescence loss, including inflammation, minor trauma, ulcers, and fungal infections. This means the device can produce false positives, flagging tissue that is not actually precancerous or cancerous. A systematic review noted that specificity varies significantly across studies. [7]
The device cannot diagnose cancer. It only highlights areas that look different under fluorescence. A biopsy and microscopic examination by a pathologist are always required for a definitive diagnosis. [1]
Operator experience matters. Clinicians who are well trained in interpreting fluorescence patterns tend to achieve better results. In the hands of a less experienced user, both false positives and false negatives are more likely. [7] Finally, VELscope does not work well for screening areas that are difficult to visualize, such as the base of the tongue or the tonsils.
- Lower specificity means some benign conditions may appear abnormal [7]
- Cannot diagnose cancer; biopsy is always needed for confirmation [1]
- Results depend on clinician training and experience [7]
- Limited access to deep oral and oropharyngeal areas
- Not a replacement for a conventional visual and tactile exam
Cost and Insurance Coverage
A VELscope screening typically costs between $25 and $75 as an add-on to a routine dental exam. Costs vary by location, provider, and case complexity.
Some dental insurance plans cover oral cancer screenings, but many consider VELscope an elective or adjunctive procedure and do not reimburse for it separately. It is worth calling your insurance provider before your appointment to ask whether the screening is covered under your plan. The ADA procedure code commonly associated with adjunctive oral cancer screening is D0431, though coverage policies differ among insurers.
VELscope devices are available in many general dental offices, but they are most commonly found in practices that focus on oral medicine, oral pathology, or that serve higher-risk patient populations. If your dentist does not have the device, they can refer you to a specialist who does.
What to Ask Your Specialist About VELscope
Asking a few questions before your screening can help you understand what to expect and how the results will be used. Here are questions worth raising with your clinician.
Start by asking how many VELscope exams the clinician performs each month. Experience with the device affects interpretation accuracy. [7] Ask whether the screening will be combined with a thorough conventional visual and tactile exam, since VELscope works best as a supplement to hands-on evaluation. [1]
If a dark area is found, ask what the next steps would be. In most cases, the clinician will recommend monitoring the area over a few weeks or scheduling a biopsy. Ask who would perform the biopsy and how long pathology results typically take.
- How often do you use VELscope in your practice?
- Will you also perform a conventional visual and tactile oral exam?
- What happens if VELscope shows an abnormal area?
- Would a biopsy be done in this office, or would I be referred to an oral pathologist?
- How often should I have a VELscope screening given my personal risk factors?
- Is this screening covered by my dental insurance?
Find an Oral Pathology Specialist Near You
If you have risk factors for oral cancer or have been told you have a suspicious lesion, a specialist can provide thorough evaluation using tools like VELscope and clinical expertise in interpreting the results. Visit the oral-pathology page on My Specialty Dentist to search for a board-certified oral pathologist in your area and learn more about what to expect during a specialist exam.
Search Oral Pathologists in Your Area